Overexpression of HOXB7 and homeobox genes characterizes multiple myeloma patients lacking the major primary immunoglobulin heavy chain locus translocations

American Journal of Hematology

Volumn 86, Issue 12, 2011, Pages

  Agnelli, Luca ^a,b,d,e   Storti, Paola ^b   Todoerti, Katia ^a   Sammarelli, Gabriella ^b   Dalla Palma, Benedetta ^b   Bolzoni, Marina ^b   Rocci, Alberto ^c   Piazza, Francesco ^d   Semenzato, Gianpietro ^d   Palumbo, Antonio ^c   Neri, Antonino ^a   Giuliani, Nicola ^b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d UNIVERSITY OF PADOVA   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HOMEODOMAIN PROTEIN; HOXA3 PROTIEN; HOXA5 PROTEIN; HOXA6 PROTEIN; HOXA7 PROTEIN; HOXB4 PROTEIN; HOXB5 PROTEIN; HOXB7 PROTEIN; HOXB8 PROTEIN; IMMUNOGLOBULIN HEAVY CHAIN; MEIS2 PROTEIN; TRANSCRIPTION FACTOR HOXA10; TRANSCRIPTION FACTOR HOXA9; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHROMOSOME; CHROMOSOME 13Q; CHROMOSOME 17P; CLINICAL ARTICLE; DISEASE SEVERITY; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE LOCUS; GENE OVEREXPRESSION; GENE TRANSLOCATION; HOX GENE; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; PRIORITY JOURNAL; QUANTITATIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; BONE MARROW; COHORT STUDIES; DATABASES, FACTUAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, HOMEOBOX; GENES, NEOPLASM; HOMEODOMAIN PROTEINS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MIDDLE AGED; MULTIGENE FAMILY; MULTIPLE MYELOMA; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PLASMA CELLS; TUMOR CELLS, CULTURED;

EID: 81355127519     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.22164     Document Type: Article

References (11)

1. Shah N, Sukumar S. The Hox genes and their roles in oncogenesis. Nat Rev Cancer 2010; 10: 361-371.
2. Bach C, Buhl S, Mueller D, et al. Leukemogenic transformation by HOXA cluster genes. Blood 2010; 115: 2910-2918.
3. Storti P, Donofrio G, Colla S, et al. HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients. Leukemia 2010; 25: 527-537.
4. Hudlebusch HR, Lodahl M, Johnsen HE, et al. Expression of HOXA genes in patients with multiple myeloma. Leuk Lymphoma 2004; 45: 1215-1217.
5. Agnelli L, Bicciato S, Mattioli M, et al. Molecular classification of multiple myeloma: A distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocations. J Clin Oncol 2005; 23: 7296-7306.
6. Dickens NJ, Walker BA, Leone PE, et al. Homozygous deletion mapping in myeloma samples identifies genes and an expression signature relevant to pathogenesis and outcome. Clin Cancer Res 2010; 16: 1856-1864.
7. Chng WJ, Kumar S, Vanwier S, et al. Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling. Cancer Res 2007; 67: 2982-2989.
8. Mulligan G, Mitsiades C, Bryant B, et al. Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib. Blood 2007; 109: 3177-3188.
9. Zhan F, Huang Y, Colla S, et al. The molecular classification of multiple myeloma. Blood 2006; 108: 2020-2028.
10. Chapman MA, Lawrence MS, Keats JJ, et al. Initial genome sequencing and analysis of multiple myeloma. Nature 2011; 471: 467-472.
11. Agnelli L, Mosca L, Fabris S, et al. A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: An integrated genomics approach reveals a wide gene dosage effect. Genes Chromosomes Cancer 2009; 48: 603-614.